Skip to main content
. 2020 Jan 21;7(2):542–550. doi: 10.1002/ehf2.12591

Table 1.

Baseline characteristics of the control subjects and elderly patients with CHF

Variables Control (n = 138) CHF (n = 934) P value
Age (years) 69 (64–76) 68 (66–74) 0.257
Male, n (%) 96 (69.6) 611 (65.4) 0.337
BMI (kg/m2) 24.51 (22.66–27.00) 24.68 (22.49–26.67) 0.886
Smoking, n (%) 54 (39.1) 411 (44.0) 0.281
Hypertension, n (%) 60 (43.5) 392 (42.0) 0.782
Diabetes, n (%) 50 (36.2) 402 (43.0) 0.131
eGFR (mL/min/1.73 m2) 104 (96–117) 75 (64–82) <0.001
TC (mmol/L) 4.01 (3.39–5.04) 4.59 (3.90–5.20) <0.001
TG (mmol/L) 1.25 (0.93–1.76) 1.50 (1.07–2.04) <0.001
HDL‐C (mmol/L) 1.04 (0.88–1.18) 1.07 (0.91–1.24) 0.057
LDL‐C (mmol/L) 2.63 (2.15–3.40) 2.68 (2.26–3.28) 0.595
RBP4 (μg/mL) 40.71 ± 7.28 46.66 ± 12.38 <0.001

BMI, body mass index; eGFR, estimated glomerular filtration rate; HDL‐C, high‐density lipoprotein cholesterol; LDL‐C, low‐density lipoprotein cholesterol; RBP4, retinol‐binding protein 4; TC, total cholesterol; TG, triglyceride.

RBP4 is presented as mean ± standard deviation. Other data are presented as median with interquartile range or number with percentage in parentheses.